|
ALT-2074
|
DB05631 |
[An organoselenium drug previously studied by Oxis International in Phase-II clinical trials for ulcerative colitis patients. Some indications of efficacy were demonstrated. BXT-51072 has enthusiastic endorsement for treatment in cardiovascular indications, primarily because of its ability to mimic the function of glutathione peroxidase.] |
|
(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone
|
DB06962 |
|
|
(1s,3r,4r,6s)-1,3,4,6-Tetrapkisphosphate
|
DB04300 |
|
|
Sodium stibogluconate
|
DB05630 |
[Sodium stibogluconate is a medicine used to treat leishmaniasis and is only available for administration by injection. It belongs to the class of medicines known as the pentavalent antimonials. Sodium stibogluconate is sold in the UK as Pentostam (manufactured by GlaxoSmithKline). Widespread resistance has limited the utility of sodium stibogluconate, and in many parts of the world, amphotericin or miltefosine are used instead. It is also being investigated as an anti-tumor agent.] |
|
5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide
|
DB06961 |
|
|
beta-D-Ribose-5-phosphate
|
DB04352 |
|
|
Ulapualide A
|
DB03021 |
|
|
Iodofiltic acid I-123
|
DB05683 |
|
|
3-[2,6,8-Trioxo-9-[(2R,3S,4R)-2,3,4,5-tetrahydroxypentyl]-3H-purin-7-yl]propyl dihydrogen phosphate
|
DB03022 |
|
|
Tert-butyl N-[(2S,5R)-6-[[(2S)-5-amino-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-benzyl-3,6-dioxo-1-phenylhexan-2-yl]carbamate
|
DB04353 |
|
|
Argadin
|
DB04350 |
|
|
5-beta-D-ribofuranosylnicotinamide adenine dinucleotide
|
DB03020 |
|
|
Aconitate Ion
|
DB04351 |
|
|
Sotirimod
|
DB05680 |
|
|
Sevuparin
|
DB15007 |
[Sevuparin is under investigation in clinical trial NCT03853421 (Placebo-controlled Study to Determine the Safety and Tolerability of Subcutaneous Doses of Sevuparin).] |
|
Flufenoxuron
|
DB15006 |
[Flufenoxuron is under investigation in clinical trial NCT00922870 (Evaluation of Hemodynamic Effects of Cascade Hemofiltration in Septic Shock).] |
|
PF-04937319
|
DB15009 |
[PF-04937319 is under investigation in clinical trial NCT01513928 (A Study To Compare The Pharmacokinetics Of Different Formulations Of PF-04937319 In Healthy Subjects).] |
|
GO-203-2C
|
DB15008 |
[GO-203-2C is under investigation in clinical trial NCT02204085 (A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia).] |
|
PF-06700841
|
DB15003 |
[PF-06700841 is under investigation in clinical trial NCT03236493 (Safety and Pharmacokinetic Study of PF-06700841 in Japanese Healthy Volunteers).] |
|
Fitusiran
|
DB15002 |
[Fitusiran is under investigation in clinical trial NCT02554773 (An Open-label Extension Study of an Investigational Drug, ALN-AT3SC, in Patients With Moderate or Severe Hemophilia A or B).] |
